BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27060458)

  • 1. Differential regulation of miR-146a/FAS and miR-21/FASLG axes in autoimmune lymphoproliferative syndrome due to FAS mutation (ALPS-FAS).
    Marega LF; Teocchi MA; Dos Santos Vilela MM
    Clin Exp Immunol; 2016 Aug; 185(2):148-53. PubMed ID: 27060458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.
    Ruiz-García R; Mora S; Lozano-Sánchez G; Martínez-Lostao L; Paz-Artal E; Ruiz-Contreras J; Anel A; González-Granado LI; Moreno-Pérez D; Allende LM
    Pediatr Res; 2015 Dec; 78(6):603-8. PubMed ID: 26334989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation.
    Magerus-Chatinet A; Stolzenberg MC; Lanzarotti N; Neven B; Daussy C; Picard C; Neveux N; Desai M; Rao M; Ghosh K; Madkaikar M; Fischer A; Rieux-Laucat F
    J Allergy Clin Immunol; 2013 Feb; 131(2):486-90. PubMed ID: 22857792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype.
    Boggio E; Aricò M; Melensi M; Dianzani I; Ramenghi U; Dianzani U; Chiocchetti A
    Pediatrics; 2013 Oct; 132(4):e1052-8. PubMed ID: 24043286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells.
    Guo Q; Zhang J; Li J; Zou L; Zhang J; Xie Z; Fu X; Jiang S; Chen G; Jia Q; Li F; Wan Y; Wu Y
    Blood; 2013 Jun; 121(24):4875-83. PubMed ID: 23645835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune lymphoproliferative syndrome due to somatic FAS mutation (ALPS-sFAS) combined with a germline caspase-10 (CASP10) variation.
    Martínez-Feito A; Melero J; Mora-Díaz S; Rodríguez-Vigil C; Elduayen R; González-Granado LI; Pérez-Méndez D; Sánchez-Zapardiel E; Ruiz-García R; Menchén M; Díaz-Madroñero J; Paz-Artal E; Del Orbe-Barreto R; Riñón M; Allende LM
    Immunobiology; 2016 Jan; 221(1):40-7. PubMed ID: 26323380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of Fas ligand expression as a novel cause of autoimmune lymphoproliferative syndrome-like disease.
    Nabhani S; Ginzel S; Miskin H; Revel-Vilk S; Harlev D; Fleckenstein B; Hönscheid A; Oommen PT; Kuhlen M; Thiele R; Laws HJ; Borkhardt A; Stepensky P; Fischer U
    Haematologica; 2015 Sep; 100(9):1189-98. PubMed ID: 26113417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revisiting autoimmune lymphoproliferative syndrome caused by Fas ligand mutations.
    Maccari ME; Schneider P; Smulski CR; Meinhardt A; Pinto F; Gonzalez-Granado LI; Schuetz C; Sica MP; Gross M; Fuchs I; Kury P; Heeg M; Vocat T; Willen L; Thomas C; Hühn R; Magerus A; Lorenz M; Schwarz K; Rieux-Laucat F; Ehl S; Rensing-Ehl A
    J Allergy Clin Immunol; 2023 May; 151(5):1391-1401.e7. PubMed ID: 36621650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 gain-of-function mutations associated with autoimmune lymphoproliferative syndrome like disease deregulate lymphocyte apoptosis and can be targeted by BH3 mimetic compounds.
    Nabhani S; Schipp C; Miskin H; Levin C; Postovsky S; Dujovny T; Koren A; Harlev D; Bis AM; Auer F; Keller B; Warnatz K; Gombert M; Ginzel S; Borkhardt A; Stepensky P; Fischer U
    Clin Immunol; 2017 Aug; 181():32-42. PubMed ID: 28579554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-98 in myocarditis and its influence on transcription of the FAS/FASL gene pair.
    Zhang BY; Zhao Z; Jin Z
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
    Rieux-Laucat F; Magérus-Chatinet A; Neven B
    J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underexpression and overexpression of Fas and Fas ligand: a double-edged sword.
    Randhawa SR; Chahine BG; Lowery-Nordberg M; Cotelingam JD; Casillas AM
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):286-92. PubMed ID: 20408337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAS Haploinsufficiency Caused by Extracellular Missense Mutations Underlying Autoimmune Lymphoproliferative Syndrome.
    de Bielke MG; Perez L; Yancoski J; Oliveira JB; Danielian S
    J Clin Immunol; 2015 Nov; 35(8):769-76. PubMed ID: 26563159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MicroRNA-149-5p Induces Apoptosis of Acute Myeloid Leukemia Cell Line THP-1 by Targeting Fas Ligand (FASLG).
    Tian P; Yan L
    Med Sci Monit; 2016 Dec; 22():5116-5123. PubMed ID: 28013316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic loss of heterozygosity, but not haploinsufficiency alone, leads to full-blown autoimmune lymphoproliferative syndrome in 1 of 12 family members with FAS start codon mutation.
    Hauck F; Magerus-Chatinet A; Vicca S; Rensing-Ehl A; Roesen-Wolff A; Roesler J; Rieux-Laucat F
    Clin Immunol; 2013 Apr; 147(1):61-68. PubMed ID: 23524443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of a FAS ligand gene variant associated with inherited feline autoimmune lymphoproliferative syndrome in British shorthair cats in New Zealand.
    Aberdein D; Munday JS; Dittmer KE; Heathcott RW; Lyons LA
    N Z Vet J; 2017 Nov; 65(6):327-331. PubMed ID: 28814155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare splicing defects of FAS underly severe recessive autoimmune lymphoproliferative syndrome.
    Agrebi N; Ben-Mustapha I; Matoussi N; Dhouib N; Ben-Ali M; Mekki N; Ben-Ahmed M; Larguèche B; Ben Becher S; Béjaoui M; Barbouche MR
    Clin Immunol; 2017 Oct; 183():17-23. PubMed ID: 28668589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.